Beurs gesloten -
Nasdaq
22:00:00 29-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
19,22
USD
|
+5,37%
|
|
+21,95%
|
+88,99%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
84,25
|
100,7
|
64,3
|
78,5
|
93,76
|
177,9
|
-
|
-
|
Bedrijfswaarde
1 |
84,25
|
100,7
|
64,3
|
78,5
|
93,76
|
177,9
|
177,9
|
177,9
|
K/w-verhouding
|
17,2
x
|
-10,9
x
|
-4,72
x
|
-3,43
x
|
-13,6
x
|
-9,96
x
|
-10,3
x
|
133
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
2,65
x
|
4,63
x
|
2,71
x
|
2,96
x
|
5,02
x
|
7,4
x
|
5,57
x
|
3,3
x
|
Bedrijfswaarde/omzet
|
2,65
x
|
4,63
x
|
2,71
x
|
2,96
x
|
5,02
x
|
7,4
x
|
5,57
x
|
3,3
x
|
Bedrijfswaarde/EBITDA
|
10.468.986
x
|
-15.663.863
x
|
-7.738.043
x
|
-17.668.809
x
|
-
|
-
|
-
|
-
|
Bedrijfswaarde/FCF
|
-
|
-
|
-
|
-4.549.025
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-0%
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Aantal aandelen (in duizenden)
|
3.883
|
3.888
|
3.892
|
5.819
|
9.219
|
9.256
|
-
|
-
|
Referentieprijs
2 |
21,70
|
25,90
|
16,52
|
13,49
|
10,17
|
19,22
|
19,22
|
19,22
|
Datum van publicatie
|
25/02/20
|
25/02/21
|
17/03/22
|
16/03/23
|
21/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
31,79
|
21,76
|
23,76
|
26,5
|
18,69
|
24,04
|
31,94
|
53,97
|
EBITDA
|
8,048
|
-6,428
|
-8,31
|
-4,443
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
4,493
|
-8,84
|
-11,22
|
-8,345
|
-15,29
|
-18,69
|
-19,46
|
2,116
|
Operationele Marge
|
14,13%
|
-40,62%
|
-47,22%
|
-31,5%
|
-81,83%
|
-77,75%
|
-60,93%
|
3,92%
|
Resultaat voor belastingen (EBT)
1 |
2,066
|
-9,196
|
-13,52
|
-19,52
|
-6,531
|
-17,87
|
-18,79
|
2,116
|
Nettowinst (verlies)
1 |
4,955
|
-9,196
|
-13,55
|
-19,6
|
-6,716
|
-17,85
|
-18,79
|
2,116
|
Nettomarge
|
15,59%
|
-42,26%
|
-57,03%
|
-73,97%
|
-35,94%
|
-74,23%
|
-58,84%
|
3,92%
|
WPA
2 |
1,260
|
-2,380
|
-3,500
|
-3,930
|
-0,7500
|
-1,930
|
-1,860
|
0,1450
|
Free Cash Flow
|
-
|
-
|
-
|
-17,26
|
-
|
-
|
-
|
-
|
FCF-marge
|
-
|
-
|
-
|
-65,13%
|
-
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
25/02/20
|
25/02/21
|
17/03/22
|
16/03/23
|
21/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
6,372
|
5,487
|
4,407
|
4,668
|
5,803
|
11,62
|
3,799
|
4,773
|
4,776
|
5,338
|
4,668
|
5,38
|
6,234
|
7,76
|
6,64
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-2,884
|
-3,521
|
-3,284
|
-3,674
|
-3,51
|
2,123
|
-4,364
|
-4,007
|
-3,025
|
-3,894
|
-4,167
|
-4,289
|
-4,784
|
-5,531
|
-
|
Operationele Marge
|
-45,26%
|
-64,17%
|
-74,52%
|
-78,71%
|
-60,49%
|
18,27%
|
-114,87%
|
-83,95%
|
-63,34%
|
-72,95%
|
-89,27%
|
-79,72%
|
-76,75%
|
-71,28%
|
-
|
Resultaat voor belastingen (EBT)
1 |
-3,341
|
-4,156
|
-3,585
|
-4,35
|
-4,194
|
-7,392
|
-3,688
|
0,928
|
-2,148
|
-1,623
|
-3,767
|
-3,922
|
-4,451
|
-5,531
|
-
|
Nettowinst (verlies)
1 |
-3,345
|
-4,16
|
-3,585
|
-4,354
|
-4,199
|
-7,457
|
-3,693
|
0,916
|
-2,196
|
-1,743
|
-3,645
|
-3,942
|
-4,367
|
-5,584
|
-
|
Nettomarge
|
-52,5%
|
-75,82%
|
-81,35%
|
-93,27%
|
-72,36%
|
-64,18%
|
-97,21%
|
19,19%
|
-45,98%
|
-32,65%
|
-78,09%
|
-73,28%
|
-70,06%
|
-71,96%
|
-
|
WPA
2 |
-0,8400
|
-1,050
|
-0,8400
|
-0,9100
|
-0,9100
|
-1,180
|
-0,4400
|
0,1000
|
-0,2400
|
-0,1900
|
-0,4067
|
-0,4267
|
-0,4833
|
-0,6000
|
-0,6500
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
16/11/21
|
17/03/22
|
17/05/22
|
9/08/22
|
15/11/22
|
16/03/23
|
30/05/23
|
15/08/23
|
21/11/23
|
21/03/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-17,3
|
-
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
0,49
|
-
|
-
|
-
|
-
|
-
|
Capex/omzet
|
-
|
-
|
2,06%
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
25/02/20
|
25/02/21
|
17/03/22
|
16/03/23
|
21/03/24
|
-
|
-
|
-
|
Laatste slotkoers
19,22
USD Gemiddelde koersdoel
28,5
USD Spread / Gemiddelde doel +48,28% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +88,99% | 178 mln. | | -3,45% | 87,17 mld. | | +1,97% | 40,1 mld. | | -16,72% | 31,38 mld. | | +57,48% | 25,12 mld. | | -14,82% | 15,59 mld. | | -8,82% | 12 mld. | | -41,58% | 11,8 mld. | | -16,29% | 11,8 mld. | | +6,89% | 8,81 mld. |
Biofarmaceutica
|